Puma Biotechnology Inc
(NAS:PBYI)
$
3
-0.21 (-6.54%)
Market Cap: 147.14 Mil
Enterprise Value: 159.44 Mil
PE Ratio: 16.67
PB Ratio: 3.00
GF Score: 56/100 
Puma Biotechnology Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020 / 06:15PM GMT
Release Date Price:
$8.85
(+5.48%)
Operator
You are live.
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
Excellent. Hi there, everyone. My name is Evan Seigerman. I'm the senior biopharma analyst here at Crédit Suisse, and it's my pleasure to have Puma Biotechnologies. And from Puma, we have Alan Auerbach, and he has a lovely corporate presentation for you. I'm going to pass it off to Alan. All yours.
Alan H. Auerbach
Puma Biotechnology, Inc. - Founder, Chairman, President, CEO & Secretary
Great. Thanks, Evan.
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
There we go. Looks good.
Alan H. Auerbach
Puma Biotechnology, Inc. - Founder, Chairman, President, CEO & Secretary
Great. Thank you. So thank you, Evan. First of all, just a reminder, I'm going to be making forward-looking statements. So on this
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers